Predictors and prognostic value of myocardial injury following stent implantation

International Journal of Cardiology

Volumn 97, Issue 2, 2004, Pages 193-198

  Ramírez Moreno, Antonio ^a   Cardenal, Rosa ^a   Pera, Carla ^b   Pagola, Carlos ^a   Guzmán, Manuel ^a   Vázquez, Eduardo ^a   Fajardo, Antonio ^a   Lozano, Cristóbal ^a   Solís, Joaquín ^c   Gassó, Manuela ^c  

^a Servicio de Cardiologia   (Spain)

^b Servicio de Anestesia   (Spain)

^c Inmunología Complejo Hospitalario de Jaén   (Spain)

Author keywords

Coronary angioplasty; Revascularization; Stent; Troponin I

Indexed keywords

CREATINE KINASE MB; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY STENT; DISEASE MARKER; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; HEART MUSCLE INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; THORAX PAIN; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MB FORM; FEMALE; FOLLOW-UP STUDIES; HEART INJURIES; HUMANS; ISOENZYMES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; STENTS; TROPONIN I;

EID: 4644353791     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.07.031     Document Type: Article

References (33)

1. Adams J.E., Bodor G.S., Davila-Roman V.G., et al. Cardiac troponin: I. A marker with high specificity for cardiac injury. Circulation. 88:1993;101-106
2. Jimenez-Navarro M., Curiel E., Alonso J., et al. Elevations of creatinine kinase following coronary intervention (in Spanish). Rev. Esp. Cardiol. 54:2001;282-288
3. Califf R.M., Adelmeguid A.E., Kuntz R.E., et al. Myonecrosis after revascularization procedures. J. Am. Coll. Cardiol. 31:1998;241-251
4. Oh J.K., Shub C., Ilstrup D.M., Reeder G.S. Creatinine kinase release after successful percutaneous transluminal coronary angioplasty. Am. Heart J. 109:1985;1225-1231
5. Klein L.W., Kramer B.L., Howard E., Lesch M. Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. J. Am. Coll. Cardiol. 17:1991;621-626
6. Ravkilde J., Nissen H., Mickley H., Andersen P.E., Thayssen P., Horder M. Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am. Heart J. 127:1994;13-20
7. Topol E.J., Yadav J.S. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation. 101:2000;570-580
8. Katus H.A., Remppis A., Neumann F.J., et al. Diagnostic efficiency of troponin T measurements in acute myocardial infarction. Circulation. 83:1991;902-912
9. García de la Villa B., Díaz-Buschmann I., Jurado J.A., et al. Value of cardiac troponin I as a diagnostic test in the investigation of chest pain (in Spanish). Rev. Esp. Cardiol. 51:1998;122-128
10. Capdevila C., Portolés M., Hernández A., Pallarés V., Cosín J. Troponin T as a possible marker of myocardial injury; its application in the stunned myocardium and silent ischaemia (in Spanish). Rev. Esp. Cardiol. 54:2001;580-591
11. Hamm C.W., Ravkilde J., Gerhardt W., et al. The prognostic value of serum troponin T in unstable angina. New Engl. J. Med. 327:1992;146-150
12. Lindahl B., Venge P., Wallentin L. for the FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 93:1996;1651-1657
13. Ottani F., Galvani M., Nicolini F.A., et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am. Heart J. 140:2000;917-927
14. Morrow D.A., Rifai N., Tanasijevic M.J., Wibenga D.R., De Lemos J.A., Antman E.M. Clinical efficacy of three assays for cardiac troponin I for the risk stratification in acute coronary syndromes: a thrombolysis in myocardial infarction (TIMI) IIb substudy. Clin. Chem. 46:2000;453-460
15. Luscher M.S., Thygesen K., Ravkilde J., Heickendorff L. for the TRIM Study Group. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary disease. Circulation. 96:1997;2578-2585
16. Fuchs S., Gruberg L., Singh S., et al. Prognostic value of cardiac troponin I re-elevation following percutaneous coronary intervention in high-risk patients with acute coronary syndromes. Am. J. Cardiol. 88:2001;129-133
17. Nageh T., Sherwood R.A., Thomas M.R. Prognostic implications of cardiac marker elevation after percutaneous intervention. Circulation. 105:2002;73
18. Ricciardi M.J., Davidson C.J., Gubernikoff G., et al. Troponin elevation and cardiac events after percutaneous coronary intervention. Am. Heart J. 145:2003;522-528
19. Nallamothu B.K., Chetcuti S., Mukherjee D., et al. Prognostic implication of troponin I elevation after percutaneous coronary intervention. Am. J. Cardiol. 91:2003;1272-1274
20. Pan M., Suarez de Lezo J., Velasco F., et al. Reduction of thrombotic and hemorrhagic complications after stent implantation. Am. Heart J. 132:(6):1996 (December);1119-1126
21. Pan M., Suárez de Lezo J., Medina A., et al. Simple and complex stent strategies for bifurcated coronary arterial stenosis involving the side branch origin. Am. J. Cardiol. 83:1999;1320-1325
22. Apple F.S., Wu A.H.B., Jaffe A.S., et al. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am. Heart J. 144:2002;981-986
23. Van de Werf F. More evidence for a beneficial effect of platelet glycoprotein IIb/IIIa blockade during coronary interventions- latest results from EPILOG and CAPTURE trials. Eur. Heart J. 17:1996;325-326
24. The EPISTENT Investigators. Ramdomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein IIb/IIIa blockade. Lancet. 352:1998;87-92
25. Anderson K.M., Califf R.M., Stone G.W., et al. Long-term mortality benefit with abciximab in patients undergoing percutaneous coronary intervention. J. Am. Coll. Cardiol. 37:2001;2059-2065
26. Blankenship J.C., Tasissa G., O'Shea J.C., et al. Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial. J. Am. Coll. Cardiol. 38:2001;653-658
27. Fuchs S., Kornowski R., Mehran R., et al. Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions. Am. J. Cardiol. 85:2000;1077-1082
28. Fuchs S., Kornowski R., Mehran R., et al. Cardiac troponin-I levels and clinical outcomes in patients with acute coronary syndromes. The potential role of early percutaneous revascularization. J. Am. Coll. Cardiol. 34:1999;1704-1710
29. Abdelmeguid A.E., Topol E.J. The myth of the myocardial "infarctlet" during percutaneous coronary revascularization procedures. Circulation. 94:1996;3369-3375
30. Wu A.H., Boden W.E., McKay R.G. Long-term follow-up of patients with increased cardiac troponin concentrations following percutaneous coronary intervention. Am. J. Cardiol. 89:2002;1300-1302
31. Bertinchant J.P., Polge A., Ledermann B., et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angor pectoris. Am. J. Cardiol. 84:1999;51-57
32. Cantor W.J., Newby L.K., Christenson R.H., et al. Prognostic significance of elevated troponin I after percutaneous coronary intervention. J. Am. Coll. Cardiol. 39:2002;1738-1744
33. Uettwiller-Geiger D., Wu A.H., Apple F.S., et al. Multicenter evaluation of an automated assay for troponin I. Clin. Chem. 48:2000;869-872